Ipriflavone

依普拉封

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameIpriflavone
Drug Alias NameOsteoquine异黄酮伊普黄酮ipriflavona异丙氧黄酮 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoclasts inhibitors
TargetsNot applicable
Therapy Area/IndicationsCognitive DysfunctionCognition DisordersAlzheimer Disease +[4] 
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaOsteoporosis
Original Approved Country/TerritoryJapan
Original Approved Date1988/12/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts General HospitalHubei Sihuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionCognition DisordersAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeM05BX01
Related LinksWikipediaKEGG